Global Blood Group Typing Market to Reach US$3.9 Billion by 2030, Fueled by Rising Transfusions and Diagnostic Innovation
Industry Experts, Inc. unveils a new report, "Blood Group Typing - A Global Market Overview," projecting that worldwide market value will climb from US$2.4 billion in 2024 to US$3.9 billion by 2030, registering a compound annual growth rate of 8.8% during the 2024–2030 forecast period.
Demand for precise, high-throughput blood group typing is intensifying as surgical procedures, trauma cases and chronic diseases such as cancer and anemia rise globally. Traditional ABO and Rh assays remain foundational, while extended antigen phenotyping and molecular genotyping, leveraging PCR, microarray and next-generation sequencing, are gaining traction. Automation, robotics and artificial intelligence are streamlining workflows, reducing manual errors and alleviating skilled-labor shortages in clinical laboratories and blood banks.
North America commands roughly 40% of global revenues, underpinned by advanced healthcare infrastructure, favorable reimbursement policies and high blood donation rates. The United States leads with continuous R&D investment driving adoption of automated typing platforms. Asia-Pacific is poised for the fastest expansion at an 11.6% CAGR as China, India and Japan scale up blood donation programs, local manufacturing and deployment of PCR and NGS-based solutions.

By product, consumables dominate with a 60.9% share in 2024, reflecting the recurring need for reagents and kits in hospitals, blood banks and laboratories. Services are the fastest-growing segment, expanding at an 11.5% CAGR as smaller facilities outsource complex molecular tests, particularly NGS panels, to specialized reference labs. By technique, PCR-based and microarray methods lead with a 42% share in 2024 due to their accuracy, speed and suitability for personalized transfusion strategies. Assay-based techniques, such as gel column and microplate formats, are set to grow at over 10% annually, driven by their affordability, scalability and compatibility with automated analyzers.
The report quantifies blood group typing market value across North America, Europe, Asia-Pacific, South America and Rest of World. It segments demand by product (consumables, instruments, services), technique (assay-based, PCR-based and microarray, massively parallel sequencing and others), test type (ABO/Rh, antibody screening, HLA typing, cross-matching and antigen typing) and end user (hospitals, diagnostic laboratories, blood banks and others). Historical data cover 2021–2023, with 2024 as the base year and forecasts through 2030, all expressed in U.S. dollars. Competitive analysis profiles more than eleven key players including Bio-Rad Laboratories, Danaher (Beckman Coulter), Grifols, Merck KGaA, QuidelOrtho and Thermo Fisher, highlighting recent assay launches, capacity expansions and AI integration partnerships that are reshaping the landscape.
About Industry Experts, Inc
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/
Comments
Post a Comment